West Pharmaceutical Services Inc (WST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, West Pharmaceutical Services Inc (WST) has a cash flow conversion efficiency ratio of 0.079x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($251.10 Million) by net assets ($3.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
West Pharmaceutical Services Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how West Pharmaceutical Services Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of West Pharmaceutical Services Inc for a breakdown of total debt and financial obligations.
West Pharmaceutical Services Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of West Pharmaceutical Services Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FIBRA Prologis
MX:FIBRAPL14
|
0.017x |
|
Merck KGaA
XETRA:MRK
|
0.052x |
|
Nextracker Inc. Class A Common Stock
NASDAQ:NXT
|
0.058x |
|
Tractor Supply Company
NASDAQ:TSCO
|
0.126x |
|
Guangdong Hec Technology Holding Co Ltd Class A
SHG:600673
|
0.025x |
|
Bank Polska Kasa Opieki SA
WAR:PEO
|
0.245x |
|
Genmab AS
NASDAQ:GMAB
|
0.051x |
|
LG Electronics Inc
KO:066570
|
0.061x |
Annual Cash Flow Conversion Efficiency for West Pharmaceutical Services Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of West Pharmaceutical Services Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see WST market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.18 Billion | $754.80 Million | 0.238x | -2.44% |
| 2024-12-31 | $2.68 Billion | $653.40 Million | 0.244x | -9.62% |
| 2023-12-31 | $2.88 Billion | $776.50 Million | 0.270x | -0.05% |
| 2022-12-31 | $2.68 Billion | $724.00 Million | 0.270x | +7.83% |
| 2021-12-31 | $2.34 Billion | $584.00 Million | 0.250x | -1.85% |
| 2020-12-31 | $1.85 Billion | $472.50 Million | 0.255x | +9.16% |
| 2019-12-31 | $1.57 Billion | $367.20 Million | 0.233x | -18.33% |
| 2018-12-31 | $1.01 Billion | $288.60 Million | 0.286x | +80.81% |
| 2017-12-31 | $1.67 Billion | $263.30 Million | 0.158x | -19.49% |
| 2016-12-31 | $1.12 Billion | $219.40 Million | 0.196x | -5.36% |
| 2015-12-31 | $1.02 Billion | $212.40 Million | 0.207x | +8.67% |
| 2014-12-31 | $958.10 Million | $182.90 Million | 0.191x | -21.53% |
| 2013-12-31 | $906.40 Million | $220.50 Million | 0.243x | -5.38% |
| 2012-12-31 | $728.90 Million | $187.40 Million | 0.257x | +28.83% |
| 2011-12-31 | $654.90 Million | $130.70 Million | 0.200x | -9.71% |
| 2010-12-31 | $625.70 Million | $138.30 Million | 0.221x | -7.04% |
| 2009-12-31 | $579.10 Million | $137.70 Million | 0.238x | -14.20% |
| 2008-12-31 | $487.10 Million | $135.00 Million | 0.277x | +5.30% |
| 2007-12-31 | $490.90 Million | $129.20 Million | 0.263x | -23.26% |
| 2006-12-31 | $419.30 Million | $143.80 Million | 0.343x | +33.86% |
| 2005-12-31 | $334.10 Million | $85.60 Million | 0.256x | +15.50% |
| 2004-12-31 | $310.60 Million | $68.90 Million | 0.222x | -17.42% |
| 2003-12-31 | $257.60 Million | $69.20 Million | 0.269x | +4.01% |
| 2002-12-31 | $208.70 Million | $53.90 Million | 0.258x | +39.64% |
| 2001-12-31 | $176.80 Million | $32.70 Million | 0.185x | -18.52% |
| 2000-12-31 | $214.10 Million | $48.60 Million | 0.227x | -24.12% |
| 1999-12-31 | $232.00 Million | $69.40 Million | 0.299x | -3.85% |
| 1998-12-31 | $228.20 Million | $71.00 Million | 0.311x | +27.81% |
| 1997-12-31 | $278.10 Million | $67.70 Million | 0.243x | -3.12% |
| 1996-12-31 | $252.30 Million | $63.40 Million | 0.251x | +38.62% |
| 1995-12-31 | $254.30 Million | $46.10 Million | 0.181x | -16.57% |
| 1994-12-31 | $229.20 Million | $49.80 Million | 0.217x | +12.31% |
| 1993-12-31 | $199.00 Million | $38.50 Million | 0.193x | +1.68% |
| 1992-12-31 | $178.70 Million | $34.00 Million | 0.190x | -30.97% |
| 1991-12-31 | $161.10 Million | $44.40 Million | 0.276x | +43.77% |
| 1990-12-31 | $187.80 Million | $36.00 Million | 0.192x | -15.64% |
| 1989-12-31 | $188.80 Million | $42.90 Million | 0.227x | -- |
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; sy… Read more